From ugly duckling to swan: Unexpected identification from cell-SELEX of an anti-annexin A2 aptamer targeting tumors

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Cibiel, Agnes ^a,b,c   Quang, Nam Nguyen ^a,b,c   Gombert, Karine ^a,b,c   Thézé, Benoit ^a,b,c   Garofalakis, Anikitos ^a,b,c   Ducongé, Frédéric ^a,b,c  

^a DIF   (France)

^b In vivo Molecular Imaging Laboratory   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACE4 APTAMER; APTAMER; ENDOTHELIN B RECEPTOR; LIPOCORTIN 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL STRAIN; CELL STRAIN CHO K1; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNALIZATION; MALIGNANT NEOPLASTIC DISEASE; MCF 7 CELL LINE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; TARGET CELL; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANNEXIN A2; APTAMERS, NUCLEOTIDE; BREAST NEOPLASMS; CHO CELLS; CRICETULUS; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INCIDENTAL FINDINGS; LIGANDS; MCF-7 CELLS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTEIN BINDING; RECEPTOR, ENDOTHELIN B; SELEX APTAMER TECHNIQUE;

EID: 84900409755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087002     Document Type: Article

References (53)

1. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
2. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
3. Tavitian B, Haberkorn U (2009) Darwinian molecular imaging. Eur J Nucl Med Mol Imaging 36: 1475-1482.
4. Fitzwater T, Polisky B (1996) A SELEX primer. Methods Enzymol 267: 275-301. (Pubitemid 26159229)
5. Gopinath SC (2007) Methods developed for SELEX. Anal Bioanal Chem 387: 171-182.
6. Aquino-Jarquin G, Toscano-Garibay JD (2011) RNA Aptamer Evolution: Two Decades of SELEction. Int J Mol Sci 12: 9155-9171.
7. Cibiel A, Pestourie C, Duconge F (2012) In vivo uses of aptamers selected against cell surface biomarkers for therapy and molecular imaging. biochimie 94: 1595-1606.
8. Keefe AD, Pai S, Ellington A (2010) Aptamers as therapeutics. Nat Rev Drug Discov 9: 537-550.
9. Pestourie C, Tavitian B, Duconge F (2005) Aptamers against extracellular targets for in vivo applications. Biochimie 87: 921-930. (Pubitemid 41297819)
10. Wang RE, Zhang Y, Cai J, Cai W, Gao T (2011) Aptamer-based fluorescent biosensors. Curr Med Chem 18: 4175-4184.
11. Palchetti I, Mascini M (2012) Electrochemical nanomaterial-based nucleic acid aptasensors. Anal Bioanal Chem 402: 3103-3114.
12. Sundaram P, Kurniawan H, Byrne ME, Wower J (2013) Therapeutic RNA aptamers in clinical trials. European Journal of Pharmaceutical Sciences 48: 259-271.
13. Dassie JP, Liu X-y, Thomas GS, Whitaker RM, Thiel KW, et al. (2009) Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotech 27: 839-846.
14. Gu F, Zhang L, Teply BA, Mann N, Wang A, et al. (2008) Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A.
15. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, et al. (2006) Tumor targeting by an aptamer. J Nucl Med 47: 668-678. (Pubitemid 46768469)
16. Hwang do W, Ko HY, Lee JH, Kang H, Ryu SH, et al. (2010) A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 51: 98-105.
17. Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC (2008) Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol 26: 442-449.
18. Pastor F, Kolonias D, Giangrande PH, Gilboa E (2010) Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature 465: 227-230.
19. Pieve CD, Perkins AC, Missailidis S (2009) Anti-MUC1 aptamers: radiolabelling with (99 m)Tc and biodistribution in MCF-7 tumour-bearing mice. Nucl Med Biol 36: 703-710.
20. Zhou J, Li H, Li S, Zaia J, Rossi JJ (2008) Novel Dual Inhibitory Function Aptamer-siRNA Delivery System for HIV-1 Therapy. Mol Ther.
21. Cibiel A, Dupont DM, Duconge F (2011) Methods To Identify Aptamers against Cell Surface Biomarkers. Pharmaceuticals 4: 1216-1235.
22. Dua P, Kim S, Lee DK (2011) Nucleic acid aptamers targeting cell-surface proteins. Methods 54: 215-225.
23. Sun W, Du L, Li M (2011) Advances and perspectives in cell-specific aptamers. Curr Pharm Des 17: 80-91.
24. Ohuchi S (2012) Cell-SELEX Technology. Biores Open Access 1: 265-272.
25. Cerchia L, Duconge F, Pestourie C, Boulay J, Aissouni Y, et al. (2005) Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase. PLoS Biol 3: e123.
26. Ohuchi SP, Ohtsu T, Nakamura Y (2005) A novel method to generate aptamers against recombinant targets displayed on the cell surface. Nucleic Acids Symp Ser (Oxf): 351-352.
27. Ohuchi SP, Ohtsu T, Nakamura Y (2006) Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. Biochimie.
28. Pestourie C, Cerchia L, Gombert K, Aissouni Y, Boulay J, et al. (2006) Comparison of different strategies to select aptamers against a transmembrane protein target. Oligonucleotides 16: 323-335. (Pubitemid 46043154)
29. Meyer S, Maufort JP, Nie J, Stewart R, McIntosh BE, et al. (2013) Development of an Efficient Targeted Cell-SELEX Procedure for DNA Aptamer Reagents. PLoS ONE 8: e71798.
30. Wang C, Zhang M, Yang G, Zhang D, Ding H, et al. (2003) Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol 102: 15-22. (Pubitemid 36369199)
31. Shangguan D, Meng L, Cao ZC, Xiao Z, Fang X, et al. (2008) Identification of liver cancer-specific aptamers using whole live cells. Anal Chem 80: 721-728. (Pubitemid 351206860)
32. Parekh P, Tang Z, Turner PC, Moyer RW, Tan W (2010) Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells. Anal Chem 82: 8642-8649.
33. Zueva E, Rubio LI, Duconge F, Tavitian B (2010) Metastasis-focused cell-based SELEX generates aptamers inhibiting cell migration and invasion. Int J Cancer 128: 797-804.
34. Blank M, Weinschenk T, Priemer M, Schluesener H (2001) Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J Biol Chem 276: 16464-16468.
35. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L (2003) A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A 100: 15416-15421. (Pubitemid 38021004)
36. Mallikaratchy P, Tang Z, Kwame S, Meng L, Shangguan D, et al. (2007) Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics 6: 2230-2238.
37. Ulrich H, Wrenger C (2009) Disease-specific biomarker discovery by aptamers. Cytometry A.
38. Berezovski MV, Lechmann M, Musheev MU, Mak TW, Krylov SN (2008) Aptamer-Facilitated Biomarker Discovery (AptaBiD). J Am Chem Soc.
39. Mazzuca MQ, Khalil RA (2012) Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol 84: 147-162.
40. Allard B, Priam F, Deshayes F, Ducancel F, Boquet D, et al. (2011) Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor. DNA Cell Biol 30: 727-737.
41. Grimshaw MJ, Hagemann T, Ayhan A, Gillett CE, Binder C, et al. (2004) A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res 64: 2461-2468. (Pubitemid 38523900)
42. Aukrust I, Hollås H, Strand E, Evensen L, Travé G, et al. (2007) The mRNA-binding Site of Annexin A2 Resides in Helices C-D of its Domain IV. Journal of Molecular Biology 368: 1367-1378. (Pubitemid 46617601)
43. Filipenko NR, MacLeod TJ, Yoon CS, Waisman DM (2004) Annexin A2 is a novel RNA-binding protein. J Biol Chem 279: 8723-8731. (Pubitemid 38295928)
44. Dassah M, Deora AB, He K, Hajjar KA (2009) The endothelial cell annexin A2 system and vascular fibrinolysis. Gen Physiol Biophys 28 Spec No Focus: F20-28.
45. Lokman NA, Ween MP, Oehler MK, Ricciardelli C (2011) The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 4: 199-208.
46. Kesavan K, Ratliff J, Johnson EW, Dahlberg W, Asara JM, et al. (2010) Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Antiangiogenic Effects. Journal of Biological Chemistry 285: 4366-4374.
47. Thiel WH, Bair T, Peek AS, Liu X, Dassie J, et al. (2012) Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection. PLoS ONE 7: e43836.
48. Li N, Nguyen HH, Byrom M, Ellington AD (2011) Inhibition of Cell Proliferation by an Anti-EGFR Aptamer. PLoS ONE 6: e20299.
49. Herve L, Koenig A, Da Silva A, Berger M, Boutet J, et al. (2007) Noncontact fluorescence diffuse optical tomography of heterogeneous media. Appl Opt 46: 4896-4906. (Pubitemid 47632043)
50. Garofalakis A, Dubois A, Kuhnast B, Dupont DM, Janssens I, et al. (2010) In vivo validation of free-space fluorescence tomography using nuclear imaging. Opt Lett 35: 3024-3026.
51. Sousa R (2000) Use of T7 RNA polymerase and its mutants for incorporation of nucleoside analogs into RNA. Methods Enzymol 317: 65-74.
52. Hansske F, Cramer F (1979) Modification of the 39 terminus of tRNA by periodate oxidation and subsequent reaction with hydrazides. Methods Enzymol 59: 172-181.
53. Li N, Ebright J, Stovall G, Chen X, Nguyen H, et al. (2009) Technical and Biological Issues Relevant to Cell Typing by Aptamers. J Proteome Res.